Entrepreneurs and business leaders across South Asia are being urged to submit their applications soon for the prestigious Seed Transformation Program offered by the Stanford Graduate School of ...

Gilead HPI licensing adds $35M now + $330M milestones; Phase 2 starts by 2026; strong cash runway. Click for this ASMB update ...

Greece's unsubsidized, 'standalone' battery storage program targeting 4.7 GW has received a massive 12.15 GW in grid connection applications. Followin ...

One of the world’s foremost defense and aerospace names, Northrop Grumman (NYSE:NOC) has been one of the strongest-performing ...

Spyre Therapeutics, Inc. earns a Strong Buy on Phase 1 wins, IBD/RA pipeline catalysts, and $757M cash runway. Click for this ...

Key combination for the treatment of first-line AML Recent data from an ongoing study in first-line AML showed a 100% overall response rate (ORR) ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that the 45th subject has been enrolled in its pivotal Phase 2B/3 MIRACLE trial evaluating Annamycin in ...

EndoCyclic Therapeutics, a biopharmaceutical company developing precision peptide therapeutics and diagnostics for complex diseases, today announced that the U.S. Food and Drug Administration (FDA) ...

This article is authored by Prateek Gupta, SVP & head, Technical Development, OneSource Specialty Pharma Limited.

A 14% yield sounds like a solution to almost every income investor’s problem. For retirees bridging the gap between Social ...

A DR5-mediated apoptotic strategy combined with irinotecan/temozolomide achieved a 64.5% ORR and 87.1% DCR in ...

According to a latest market analysis by Future Market Insights, the global laser cutting machines market is projected to grow from USD 6.9 billion in 2025 to USD 14.3 billion by 2035, registering a ...